NCT00287586View on ClinicalTrials.gov

Testosterone Replacement in Older Men and Atherosclerosis Progression

PHASE4CompletedINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 7, 2012

Study Completion Date

May 12, 2012

Conditions
HypogonadismAtherosclerosis
Interventions
DRUG

Testosterone Gel (Androgel)

7.5 g of 1% testosterone gel to achieve a nominal delivery of 75 mg testosterone daily for 3 years

DRUG

Placebo

Placebo-matching testosterone gel daily for 3 years

Trial Locations (3)

85016

Kronos Longevity Research Institute, Phoenix

90059

Charles R. Drew University of Medicine and Science, Los Angeles

02118

Boston University / Boston Medical Center, Boston

All Listed Sponsors
collaborator

Solvay Pharmaceuticals

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT00287586 - Testosterone Replacement in Older Men and Atherosclerosis Progression | Biotech Hunter | Biotech Hunter